Health

HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program

* Applications for physicians trained in Indonesia now open until April 15, 2023 12:00 AM * The Pharmaceutical Industry Fellowship Program provides physicians with the opportunity to experience the various steps of the drug development process ROCKVILLE, Md. and SEOUL, South Korea, March 15, ...

2023-03-15 19:00 1817

Nippon Express (Belgium) Joins Pharma.Aero

TOKYO, March 15, 2023 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A. (hereinafter "NX Belgium"), a group company of NIPPON EXPRESS HOLDINGS, INC., became the first Japanese forwarder to join Pharma.Aero (*) onJanuary 25 this year. Pharma.Aero logo: https://kyodonewsprwire.jp/img/202303033576...

2023-03-15 14:00 1679

Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting

BEIJING and SHANGHAI and BOSTON, Mass., March 14, 2023 /PRNewswire/ -- Jacobin Pharma (1167.HK) today announced that the company will present the results of three preclinical studies of KRASmulti inhibitor JAB-23425, CD73-STING iADC JAB-X1800, and Aurora kinase A inhibitor JAB-2485 in form of the...

2023-03-15 10:45 2977

Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting

SUZHOU, China and ROCKVILLE, Md., March 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest results from three preclinical s...

2023-03-15 07:59 2874

Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011

SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single cente...

2023-03-14 23:42 2209

Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma

NANJING, China, March 14, 2023 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) (Simcere), an innovative global biopharmaceutical company, announced today that Simcere Zaiming, an innovative oncology pharmaceutical company of Simcere has entered into a clinical collaboration agreeme...

2023-03-14 20:00 2478

So-Young to Report Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

BEIJING, March 14, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its fina...

2023-03-14 17:30 2029

Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer

HONG KONG, March 14, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-specific antibody, AK104), the world's first approved and marketed dual-immune checkpoint bi-specific antib...

2023-03-14 17:01 1382

OSANO Debuts Latest Products at COSMOPROF 2023

BOLOGNA, Italy, March 14, 2023 /PRNewswire/ -- COSMOPROF WORLDWIDE BOLOGNA, one of the most influential global events dedicated to all facets of the beauty industry,is taking place from the 17th to 20th, March, 2023. OSANO launched a series of top-notch products, including Beauty Equipment, Body ...

2023-03-14 16:48 1479

DeepCare debuts at IDS Cologne 2023

COLOGNE, Germany, March 14, 2023 /PRNewswire/ -- DeepCare, a leading AI solution provider for dental care, debuts its latest innovative products at the International Dental Show (IDS) inCologne, Germany, from March 14th to 18th, 2023. IDS is the world's largest and most influential dental exhibit...

2023-03-14 16:00 1667

Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar

International partnership will see sensor installations in senior care facilities in all of Austco's operating regions, includingAustralia, the UK, Canada, and the US. DALLAS and TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Austco , an international manufacturer of n...

2023-03-13 22:00 2166

Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction

SHANGHAI, March 13, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the survey results of bone marrow patient services provided by ...

2023-03-13 20:00 2021

Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors

SUZHOU, China, March 13, 2023 /PRNewswire/ -- On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a strategic partnership to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-...

2023-03-13 20:00 1687

AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease

TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S.,Canada, European Union, Great Britain, and Israel for spinal ...

2023-03-10 19:00 1671

Success for Surglasses Technology! First AR Surgery Completed in the United States

TAICHUNG, Taiwan, March 10, 2023 /PRNewswire/ -- Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging. Surglasses has achieved a signifi...

2023-03-10 16:26 1817

Safeguard "Children of the Stars" - Soul App's New Campaign Inspires Young Users

SHANGHAI, March 9, 2023 /PRNewswire/ -- "Thank you all. It was heartwarming. (We will) keep going," said a message left by a parent of an autistic child in an online group chat party. In China, children with autism are also known as "children of the stars", due to the different way in which they...

2023-03-10 11:21 1738

Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing

BOSTON, March 9, 2023 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a$50 million Series B financing round, co-led by INCE Capital and Qiming Venture Partners, w...

2023-03-10 09:00 1954

Hugel Nominates Suk-yong Cha as Non-Executive Director

* Hugel's 22nd General shareholders' meeting to take place on March 30th * Proposed appointment of Suk-yong Cha as new non-executive director as an agenda item SEOUL, South Korea, March 9, 2023 /PRNewswire/ -- Hugel, a global total medical aesthetic company, announced onMarch 9th that it wil...

2023-03-09 23:00 2089

Chamlion, the world's first dental 3D printing service cloud platform will appear at the IDS

COLOGNE, Germany, March 9, 2023 /PRNewswire/ -- On March 14, Chamlion, a digital dental expert, will appear at the IDS inGermany, exhibiting the world's first dental 3D printing service cloud platform at booth K091 in Hall 11.3, providing one-stop solutions for global dental processing customers....

2023-03-09 22:00 2120

Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 17, 2023

BEIJING, March 9, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the fourth quarter a...

2023-03-09 19:45 2968
1 ... 9899100101102103104 ... 273